Cancer Clinical Trials Office
The primary mission of the Cancer Clinical Trials Office (CCTO) is to assist The Tisch Cancer Institute (TCI) investigators in the development, conduct, and reporting of innovative clinical research in an efficient, compliant, and scientifically sound manner. The CCTO is composed of regulatory, financial, clinical, study management, compliance, and data management personnel that support investigators and provide uniformity and consistency in clinical research. The CCTO provides management and oversight functions for coordinating, facilitating, and reporting on the cancer clinical trials that complement the Protocol Review and Monitoring System (PRMS). There is a Quality Assurance Program (QAP) responsible for centralized education and training services, subject central registration, auditing, and the development of policy, which supports the TCI Data and Safety Monitoring Committee (DSMC) to ensure data integrity, while promoting subject safety.